Dynemic Products (DYNPRO)

Score breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 1/2 · Dividend: 0/1

Key Financials

Strengths

• Low leverage with debt/equity at 0.34 and Piotroski F-Score of 6/9.
• Positive net profit growth of 5.01% despite falling sales, showing some resilience.
• P/B of 1.41 with book value of ₹170.49 provides an asset cushion near the current price.
• The company is profitable with P/E of 16.21 and ROCE of 10.01%.

Concerns

• Sales declining at -5.10% raises questions about demand and competitive moat.
• ROE of 8.51% is mediocre and below what I look for in a compounding business.
• Zero dividend yield means shareholders receive no income while waiting.
• Low promoter holding of 29.42% and high PEG of 3.24 are governance and valuation red flags.

AI Analysis

At ₹241.15, Dynemic Products is a small specialty-chemical player with a market cap of just ₹288 crore. I always prefer businesses with a clear durable moat; here I see a modest, financially sound operation but no obvious franchise strength. It is profitable—P/E of 16.21 and ROE of 8.51%—yet those returns are far from mouth-watering. The balance sheet is okay: debt-to-equity is 0.34 and the Piotroski F-Score is 6/9, so I don't see distress. Book value of ₹170.49 and a P/B of 1.41 give some asset support, and the stock sits near the lower end of its 52-week range, down from ₹415.80. That decline could create value, or it could reflect a deteriorating reality. Sales are falling (-5.10%), while net profit rose a modest 5.01%. That divergence is often the result of cost cuts or accounting noise, not compounding. With a PEG of 3.24, the market is pricing this above its actual growth; at 16 times earnings I get no margin of safety. Worse, there is no dividend, so as a minority shareholder I earn nothing while I wait. Promoter holding of 29.42% also bothers me—for an Indian small-cap, I'd want owners with much more skin in the game. The latest quarter—sales of ₹91 crore and net profit of ₹5 crore—isn't enough to prove a turnaround. In Graham's language, price is what you pay, value is what you get; I'm uncertain the value is here. I will wait for either a better price or a clear return to sales growth before this can be called an investment.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer